L & S Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-9,330
| Closed | -$1.36M | – | 235 |
|
|
2022
Q2 | $1.36M | Buy |
+9,330
| New | +$1.36M | 0.23% | 103 |
|
|
2020
Q3 | – | Sell |
-4,750
| Closed | -$704K | – | 298 |
|
|
2020
Q2 | $704K | Buy |
4,750
+2,409
| +103% | +$357K | 0.11% | 198 |
|
|
2020
Q1 | $255K | Sell |
2,341
-2,902
| -55% | -$316K | 0.05% | 215 |
|
|
2019
Q4 | $604K | Buy |
+5,243
| New | +$604K | 0.08% | 195 |
|